Drug recalls: Ignorance isn’t bliss

In perhaps the largest related series of drug recalls in U.S. history, Johnson & Johnson's McNeil Consumer Healthcare subsidiary has pulled millions of bottles of over-the-counter drugs, including some Tylenol, Benadryl, and Motrin, from pharmacy shelves since September 2009. (These drugs may have manufacturing-quality problems or may have been tainted by a chemical.) However, useful consumer information about recalls may go unreported. What's lacking?

Numbers

The drugmaker typically announces the number of recalled "lots," a manufacturing term with no standard definition. The FDA can't force a company to disclose to the public specifics about the number of tablets, bottles, or people affected. It also lacks the power of the Consumer Product Safety Commission and National Highway Transportation and Safety Administration, both of which can force a recall.

Location

The manufacturer is not required to tell the public which retail stores sold the drugs, although announcements often reveal the state and country.

Timeliness

When a prescription drug is recalled, many pharmacies and membership stores can contact each affected customer. But for over-the-counter drugs, consumers often have to rely on media reports, dig through FDA or manufacturer websites, or ask a pharmacist. For the recent recalls, Johnson & Johnson provides information at 888-222-6036 and at www.mcneilproductrecall.com.

Drug manufacturers usually release their own recall announcements. The FDA then reposts those releases. However, we found a potential timing issue. In a recent recall of free samples of the prescription blood thinner Coumadin (warfarin), the manufacturer seems to have initiated a recall well before the company's news release was posted. The company sent a letter to health-care practitioners dated June 25, but the public release was dated July 12. The FDA reposted the release on the 12th and posted its own safety alert on the 14th.